Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pathogen cell membranes and cell walls represent the primary structural defenses of bacteria, fungi, and certain parasites, serving as essential barriers against osmotic stress and host immune factors. In bacteria, the cell wall is primarily composed of peptidoglycan, a complex polymer whose synthesis is targeted by major antibiotic classes like beta-lactams and glycopeptides (StatPearls, 2023). Fungal cell walls contain unique polysaccharides such as chitin and beta-glucans, while their membranes utilize ergosterol instead of cholesterol, providing specific targets for echinocandins and polyenes, respectively (Nature Reviews Microbiology, 2017). Because these structures are often unique to microbes, they offer a high degree of selective toxicity, making them some of the most successful targets in clinical medicine. However, direct membrane-disrupting agents, such as polymyxins, can sometimes exhibit toxicity in humans due to similarities between pathogen and host lipid bilayers (PubMed, 2021). The clinical utility of targeting these structures is increasingly threatened by the evolution of resistance mechanisms, including the modification of target sites, cell wall thickening, and the upregulation of efflux pumps.
Drugs targeting these structures work by either inhibiting the biosynthesis of essential structural components, such as peptidoglycan cross-linking (beta-lactams) or beta-glucan synthesis (echinocandins), or by directly disrupting the physical integrity of the lipid membrane through pore formation or detergent-like action (polymyxins, polyenes), leading to cytoplasmic leakage and cell death.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pathogen cell membranes and cell walls.